General MedicationsSUBCUTANEOUS LYOPHILIZED POWERStandard
PORCINE SECRETIN
PORCINE SECRETIN
Standard Dose
16MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PORCINE SECRETIN is listed in Drugs@FDA under application 021209 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PORCINE SECRETIN Form and strength INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER - 16MCG Sponsor CHIRHOCLIN Submission history Latest submission status date: 2016-10-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview PORCINE SECRETIN is listed in Drugs@FDA under application 021209 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PORCINE SECRETIN Form and strength INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER - 16MCG Sponsor CHIRHOCLIN Submission history Latest submission status date: 2016-10-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.